{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:33:21Z","timestamp":1777682001316,"version":"3.51.4"},"reference-count":52,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Hosp Pharm"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Radiocontrast agents are widely used in imaging procedures; however, their safety profile in elderly patients remains inadequately characterized. This study aims to evaluate the adverse drug events (ADEs) reported with radiocontrast iodine in this vulnerable population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted using the US FDA Adverse Event Reporting System database. Reports pertaining to adverse events linked to radiocontrast iodine in patients aged 65 and older were extracted. Signal detection was performed using frequentist and Bayesian methods to identify significant ADEs and their relationship with specific radiocontrast agents. Demographic characteristics and outcomes were also assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Out of 29\u2009153\u2009222 reports in the AERS database, 2640 unique reports related to adverse events in the elderly population were included. Key findings revealed significant signals including hypersensitivity reactions, cardiac disorders, renal failure, pancreatitis, and neuropsychiatric events. Notably, distinct adverse effects were observed for individual agents: iodixanol was linked to pancreatitis and vasculitis, while iohexol was associated with hyperthyroidism. Additionally, the study noted that 11.6% of reported cases resulted in death, 22.1% of reported adverse events were life-threatening, and 34.8% of reported cases required hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study underscores the importance of vigilance in monitoring ADEs associated with radiocontrast iodine in elderly patients. Although common reactions were identified, emergent signals such as pancreatitis and neuropsychiatric events warrant further investigation to establish causality and improve patient safety. Future research should focus on prospective studies and the development of risk assessment tools tailored for this demographic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/00185787261427433","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:58:03Z","timestamp":1774335483000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Adverse Drug Event Profile of Radiocontrast Iodine in Elderly: A Retrospective Focused Pharmacovigilance-Based Disproportionality Analysis Study"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3811-6503","authenticated-orcid":false,"given":"Kannan","family":"Sridharan","sequence":"first","affiliation":[{"name":"Arabian Gulf University, Manama, Kingdom of Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gowri","family":"Sivaramakrishnan","sequence":"additional","affiliation":[{"name":"Bahrain Defence Force Royal Medical Services, Riffa, Kingdom of Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijabmr.IJABMR_322_19"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2004.12.020"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2008.05479.x"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.01.012"},{"issue":"5","key":"e_1_3_3_6_2","article-title":"Intravenous radiocontrast media: a review of allergic reactions","volume":"37","author":"Saljoughian M.","year":"2012","unstructured":"Saljoughian M. Intravenous radiocontrast media: a review of allergic reactions. US Pharmacist. 2012;37(5):HS-14-HS-16.","journal-title":"US Pharmacist"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.176.6.1761385"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.4329\/wjr.v9.i9.339"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-024-11114-7"},{"key":"e_1_3_3_10_2","article-title":"Acute kidney injury by radiographic contrast media: pathogenesis and prevention","volume":"1","author":"Andreucci M","year":"2014","unstructured":"Andreucci M, Faga T, Pisani A, Sabbatini M, Michael A. Acute kidney injury by radiographic contrast media: pathogenesis and prevention. Biomed Res Int. 2014;1:362725.","journal-title":"Biomed Res Int"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3292"},{"issue":"4","key":"e_1_3_3_12_2","first-page":"363","article-title":"Thyroid functions after contrast agent administration for coronary angiography: a prospective observational study in euthyroid patients","volume":"13","author":"\u00d6zkan S","year":"2013","unstructured":"\u00d6zkan S, Oysu AS, Kayata K, et al. Thyroid functions after contrast agent administration for coronary angiography: a prospective observational study in euthyroid patients. Anadolu Kardiyol Derg. 2013;13(4):363-369.","journal-title":"Anadolu Kardiyol Derg"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1089\/1050725041517075"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1258\/ar.2012.120326"},{"key":"e_1_3_3_15_2","first-page":"741018","article-title":"Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention","volume":"1","author":"Andreucci M","year":"2014","unstructured":"Andreucci M, Solomon R, Tasanarong A. Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. Biomed Res Int. 2014;1:741018.","journal-title":"Biomed Res Int"},{"key":"e_1_3_3_16_2","unstructured":"FDA. FDA\u2019s Adverse Event Reporting System (FAERS). Accessed October 21 2024. https:\/\/www.fda.gov\/drugs\/surveillance\/fdas-adverse-event-reporting-system-faers"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03500210065033"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90895-N"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2003.20130.x"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-020-00911-w"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199920020-00002"},{"key":"e_1_3_3_22_2","unstructured":"FDA. Adverse Event Reporting System (FAERS) Public Dashboard. Accessed October 21 2024. https:\/\/www.fda.gov\/drugs\/fdas-adverse-event-reporting-system-faers\/fda-adverse-event-reporting-system-faers-public-dashboard"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2019.01.006"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/pst.524"},{"key":"e_1_3_3_25_2","unstructured":"Iodixanol package insert. Accessed October 21 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/020351s054 020808s032lbl.pdf"},{"key":"e_1_3_3_26_2","unstructured":"Iohexol label. Accessed October 21 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/018956s099lbl.pdf"},{"key":"e_1_3_3_27_2","unstructured":"Iomeprol label. Accessed October 21 2024. https:\/\/www.drugs.com\/pro\/iomeron-injection.html"},{"key":"e_1_3_3_28_2","unstructured":"Iopamidol label. Accessed October 21 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/018735s057lbl.pdf"},{"key":"e_1_3_3_29_2","unstructured":"Iopromide label. Accessed October 21 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/021425s028lbl.pdf"},{"key":"e_1_3_3_30_2","unstructured":"Ioversol label. Accessed October 21 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/019710s054 020923s019lbl.pdf"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-024-01423-7"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.15441\/ceem.17.261"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.135.11.1280"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(94)95457-7"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1994.01420310038006"},{"issue":"7","key":"e_1_3_3_36_2","first-page":"1384","article-title":"A retrospective analysis of the effect of contrast-enhanced CT on the outcome of acute pancreatitis","volume":"91","author":"McMenamin DA","year":"1996","unstructured":"McMenamin DA, Gates LKJr. A retrospective analysis of the effect of contrast-enhanced CT on the outcome of acute pancreatitis. Am J Gastroenterol. 1996;91(7):1384-1387.","journal-title":"Am J Gastroenterol"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-101961"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-023-01415-y"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rxeng.2020.03.009"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-020-02408-7"},{"key":"e_1_3_3_41_2","first-page":"218","article-title":"Re: Di Chiro G, Schellinger D. Computed tomography of spinal cord after lumbar intrathecal introduction of metrizamide (computer assisted myelography)","volume":"22","author":"Wolpert SM","year":"2001","unstructured":"Wolpert SM. In Re: Di Chiro G, Schellinger D. Computed tomography of spinal cord after lumbar intrathecal introduction of metrizamide (computer assisted myelography). AJNR Am J Neuroradiol. 2001;22:218-221.","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-3019(86)90336-8"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.151.3.6371890"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1365"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004424-198809001-00042"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)90149-7"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.44.416"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.7461\/jcen.2017.19.3.184"},{"key":"e_1_3_3_49_2","article-title":"Contrast-induced neurotoxicity following cardiac catheterization","volume":"1","author":"Law S","year":"2012","unstructured":"Law S, Panichpisal K, Demede M, et al. Contrast-induced neurotoxicity following cardiac catheterization. Case Rep Med. 2012;1:267860.","journal-title":"Case Rep Med"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1177\/159101991201800105"},{"key":"e_1_3_3_51_2","first-page":"78","article-title":"Radiocontrast-related leukocytoclastic vasculitis misdiagnosed as diabetic foot ulcer in a Type 2 diabetic patient: a case report","volume":"17","author":"Sariakcali B","year":"2013","unstructured":"Sariakcali B, Sert M, Evran M, Tetiker T. Radiocontrast-related leukocytoclastic vasculitis misdiagnosed as diabetic foot ulcer in a Type 2 diabetic patient: a case report. Turk Jem. 2013;17:78-80.","journal-title":"Turk Jem"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.dad.0000181109.54532.c5"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1990.tb02079.x"}],"container-title":["Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00185787261427433","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00185787261427433","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00185787261427433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:41:36Z","timestamp":1777452096000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00185787261427433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":52,"alternative-id":["10.1177\/00185787261427433"],"URL":"https:\/\/doi.org\/10.1177\/00185787261427433","relation":{},"ISSN":["0018-5787","1945-1253"],"issn-type":[{"value":"0018-5787","type":"print"},{"value":"1945-1253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"article-number":"00185787261427433"}}